Utah Medical Products, Inc.
UTMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $215,329 | $306,296 | $365,628 | $364,700 |
| - Cash | $82,976 | $92,868 | $75,052 | $60,974 |
| + Debt | $338 | $295 | $341 | $396 |
| Enterprise Value | $132,691 | $213,723 | $290,917 | $304,122 |
| Revenue | $40,903 | $50,224 | $52,281 | $49,054 |
| % Growth | -18.6% | -3.9% | 6.6% | – |
| Gross Profit | $24,143 | $30,038 | $32,196 | $30,917 |
| % Margin | 59% | 59.8% | 61.6% | 63% |
| EBITDA | $16,440 | $24,752 | $26,872 | $26,164 |
| % Margin | 40.2% | 49.3% | 51.4% | 53.3% |
| Net Income | $13,874 | $16,635 | $16,473 | $14,788 |
| % Margin | 33.9% | 33.1% | 31.5% | 30.1% |
| EPS Diluted | 3.96 | 4.57 | 4.52 | 4.04 |
| % Growth | -13.3% | 1.1% | 11.9% | – |
| Operating Cash Flow | $14,831 | $22,281 | $21,147 | $21,203 |
| Capital Expenditures | -$235 | -$639 | -$818 | -$552 |
| Free Cash Flow | $14,596 | $21,642 | $20,329 | $20,651 |